Alberto Álvarez‐Larrán

Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status.

Eduardo Arellano‐Rodrigo, Alberto Álvarez‐Larrán, Neus Villamor et al. · PubMed · 2006 · 275 citations

Medicine, Hematology, Pathology +17

Thrombosis in primary myelofibrosis: incidence and risk factors

Tiziano Barbui, Alessandra Carobbio, Francisco Cervantes et al. · Blood · 2009 · 259 citations · Full text

Medicine, Hematology, Internal Medicine +14

Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia

Alberto Álvarez‐Larrán, Francisco Cervantes, Arturo Pereira et al. · Blood · 2010 · 234 citations · Full text

Medicine, Hematology, Pharmacotherapy +12

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera

Alberto Álvarez‐Larrán, Arturo Pereira, Francisco Cervantes et al. · Blood · 2011 · 227 citations · Full text

Medicine, Hematology, Oncology +6

Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients

Francisco Cervantes, Alberto Álvarez‐Larrán, Carme Talarn et al. · British Journal of Haematology · 2002 · 159 citations · Full text

Medicine, Hematology, Pathology +11